JP2017514845A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514845A5
JP2017514845A5 JP2016565665A JP2016565665A JP2017514845A5 JP 2017514845 A5 JP2017514845 A5 JP 2017514845A5 JP 2016565665 A JP2016565665 A JP 2016565665A JP 2016565665 A JP2016565665 A JP 2016565665A JP 2017514845 A5 JP2017514845 A5 JP 2017514845A5
Authority
JP
Japan
Prior art keywords
formula
compound
molar equivalents
present
amine base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016565665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514845A (ja
Filing date
Publication date
Priority claimed from US14/689,610 external-priority patent/US9701687B2/en
Application filed filed Critical
Publication of JP2017514845A publication Critical patent/JP2017514845A/ja
Publication of JP2017514845A5 publication Critical patent/JP2017514845A5/ja
Pending legal-status Critical Current

Links

JP2016565665A 2014-05-05 2015-04-28 オピオイド化合物を調製するプロセス Pending JP2017514845A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461988508P 2014-05-05 2014-05-05
US61/988,508 2014-05-05
US14/689,610 US9701687B2 (en) 2014-05-05 2015-04-17 Process for the preparation of opioid compounds
US14/689,610 2015-04-17
PCT/US2015/027906 WO2015171353A2 (en) 2014-05-05 2015-04-28 Process for the preparation of opioid compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020036660A Division JP2020203872A (ja) 2014-05-05 2020-03-04 オピオイド化合物を調製するプロセス

Publications (2)

Publication Number Publication Date
JP2017514845A JP2017514845A (ja) 2017-06-08
JP2017514845A5 true JP2017514845A5 (enExample) 2018-06-14

Family

ID=54354747

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016565665A Pending JP2017514845A (ja) 2014-05-05 2015-04-28 オピオイド化合物を調製するプロセス
JP2020036660A Pending JP2020203872A (ja) 2014-05-05 2020-03-04 オピオイド化合物を調製するプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020036660A Pending JP2020203872A (ja) 2014-05-05 2020-03-04 オピオイド化合物を調製するプロセス

Country Status (7)

Country Link
US (1) US9701687B2 (enExample)
EP (1) EP3140307A2 (enExample)
JP (2) JP2017514845A (enExample)
CN (1) CN107074869A (enExample)
AU (1) AU2015256507B2 (enExample)
CA (1) CA2947022A1 (enExample)
WO (1) WO2015171353A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3001689A1 (en) * 2015-10-12 2017-04-20 Noramco, Inc. Process for the preparation of (s)-2-((4r,4as,6r,7r,7ar,12bs)-7,9-dimethoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-6-yl)-3,3-dimethylbutan-2-ol

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
CA2670136A1 (en) 2006-11-22 2008-05-29 Progenics Pharmaceuticals, Inc. 7,8-saturated-4,5-epoxy-morphinanium analogs
CN101610770A (zh) * 2006-11-22 2009-12-23 普罗基因制药公司 7,8-饱和-4,5-环氧-吗啡烷离子类似物
CN101541808A (zh) * 2007-05-04 2009-09-23 马林克罗特公司 制备6-α-羟基-N-烷基化的阿片的改进的方法
DE602008004245D1 (de) 2007-05-04 2011-02-10 Mallinckrodt Inc Verbessertes verfahren zur herstellung von 6-alpha-hydroxy-n-alkylierten opiaten
US8962841B2 (en) 2007-06-29 2015-02-24 Brock University Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
CN101861315B (zh) 2007-11-20 2013-01-16 日产化学工业株式会社 2-氮杂金刚烷类的制造方法
US8546572B2 (en) * 2008-03-31 2013-10-01 Sun Pharmaceutical Industries Limited Process for the preparation of morphinane analogues
EP2328900B1 (en) 2008-08-11 2013-08-28 Tasmanian Alkaloids Pty. Ltd. PROCESS FOR MAKING MORPHINAN-6 alpha-OLS
WO2010039209A2 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the synthesis of tertiary amines
US8227608B2 (en) 2008-09-30 2012-07-24 Mallinckrodt Llc Processes for increasing the yield of opiate alkaloid derivatives
ES2477190T3 (es) 2008-09-30 2014-07-16 Mallinckrodt Llc Procedimiento de reciclaje para aumentar el rendimiento de una reacción de Grignard en la preparación de derivados alcaloides opiáceos
CA2738089C (en) 2008-09-30 2017-07-18 Mallinckrodt Inc. Processes for the hydrogenation of opiate alkaloid derivatives
EP2342207B1 (en) 2008-09-30 2015-11-11 Mallinckrodt LLC Processes for the alkylation of norbuprenorphine with reduced impurity formation
EP2398808B1 (en) 2009-02-17 2013-11-20 Mallinckrodt LLC Process for the reductive alkylation of normorphinans
WO2010121369A1 (en) 2009-04-24 2010-10-28 Brock University Processes for the preparation of morphinane and morphinone compounds
US20110269964A1 (en) * 2010-04-29 2011-11-03 Mallinckrodt Inc. N-Alkylation of Opiates
EA022266B1 (ru) * 2010-11-05 2015-11-30 Х. Лундбекк А/С Способ получения налтрексона
AU2012250451B9 (en) * 2011-05-02 2017-02-02 Brock University Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents
GB2560284B (en) 2011-10-03 2019-01-09 Johnson Matthey Plc Process for the 3-O-demethylation of morphinan compounds
CA2863242A1 (en) 2012-02-03 2013-08-08 Tomas Hudlicky Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans
US20140155608A1 (en) * 2012-05-03 2014-06-05 H. Lundbeck A/S Method for the manufacturing of naltrexone

Similar Documents

Publication Publication Date Title
JP2022043078A5 (enExample)
AU2015369668B2 (en) Processes for preparing ASK1 inhibitors
JP2013520519A5 (enExample)
JP2013505259A5 (enExample)
JP2016512822A5 (enExample)
JP2012515142A5 (enExample)
CA2934531C (en) Process methods for phosphatidylinositol 3-kinase inhibitors
TWI454464B (zh) 哌衍生物的製備方法
JP2016520672A5 (enExample)
BR112015021540B1 (pt) Processos para a preparação de um agente indutor de apoptose
JP2018507858A5 (enExample)
JP2018502174A5 (enExample)
JP6705461B2 (ja) イソシアネート化合物の製造方法
JP2013520488A5 (enExample)
JP2008530106A5 (enExample)
JP2017514845A5 (enExample)
JP2017514846A5 (enExample)
JP2018065817A5 (enExample)
JP2020502077A5 (enExample)
JP2015531767A5 (enExample)
JP2013241421A5 (enExample)
JP2018515468A5 (enExample)
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
CN107501153B (zh) 一种2-(2,2,2-三氟乙基)-3-芳基-2h-氮杂丙烯啶化合物的制备方法
CN104860856A (zh) 一种无碱绿色合成异硫氰酸酯的方法